Patient guides

Plain-language guides, written by patients.

The information your insurer, your prescriber's printed handout, and the drug manufacturer's website don't cover — synthesized from clinical trials, FDA filings, and patient experience. More guides land here as patient-authors contribute them.

Featured guide · Tirzepatide

Mounjaro for Diabetes

By Gwynne Sullivan, Jeaneth Stephani & Amy Nowacoski — admins of the Mounjaro for Diabetes Facebook group

75 answered questions across eight topics: how Mounjaro works, blood sugar & A1C, weight loss, dosing & titration, side effects, insurance access, comorbidities & special topics, and how it compares to Ozempic and Trulicity. Every answer is patient-tested and cited where research exists.

  • What is Mounjaro?
  • Blood sugar & A1C
  • Weight loss
  • Dosing & titration
  • Side effects
  • Access & coverage
  • Comorbidities
  • Drug comparisons

Read the full guide →

75 Q&As

8 topics

~150 cited sources

More guides coming.

These are the next guides on our list. If you're a patient advocate, group admin, or clinician who'd like to contribute one, get in touch.

  • Ozempic

    semaglutide — weekly injection

  • Wegovy

    semaglutide for weight loss

  • Trulicity

    dulaglutide — weekly injection

  • Metformin

    first-line oral therapy

  • Jardiance

    empagliflozin — SGLT2 inhibitor

  • Insulin

    basal & rapid-acting regimens